Type 1 diabetics had a lower risk of heart attack and stroke than patients with type 2 diabetes The researchers obtained data from the 2017-2022 Veradigm Metabolic Registry (VMR), which ...

Adding the glucagon-like peptide 1 receptor agonist (GLP-1 RA) liraglutide to standard therapy reduces the risk for recurrent stroke in patients with type 2 diabetes (T2D) and a minor acute ...

Both chronic conditions are associated with an increased risk of stroke and heart attack. A new study has found a medication already used to treat people who have type 2 diabetes and/or chronic ...

Sotagliflozin significantly reduces heart attacks and strokes in high-risk patients with diabetes and kidney disease, ...

Sotagliflozin, a dual SGLT1/2 inhibitor, reduces cardiovascular events in people with diabetic kidney disease — ischemic ...

Diabetes mellitus type 1 (DM1) is associated with lower probability of incident cardiovascular events than type 2 (DM ...

Researchers from the German Diabetes Center (DDZ) and the Heinrich Heine University Düsseldorf (HHU) have studied the ...

Tandem Diabetes Care announced that the FDA cleared its Control-IQ+ automated insulin delivery algorithm for people with type ...

An anti-inflammatory diet boosts nutrients that stave off dementia and chronic disease.

“Type 2 diabetes affects millions of Americans and increases the risk of serious health conditions, including heart disease, ...